Human opticin reduces pathological preretinal neovascularization in the mouse model of oxygen-induced retinopathy (2017)
Attributed to:
Development of an opticin-based anti-angiogenic therapeutic for the treatment of ocular disease.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 58